EUVIMEDEUVIMED entdecken
Crossref

Unlocking the Potential of HER2-Targeted Treatments

Morten Mau Sorensen, Kristian Egebjerg

EU Research · 2025-03 · Spring 2025 (41) · 12-13

DOI: 10.56181//imii5025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EU Research, 2025-03. Verfasst von Morten Mau Sorensen und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We spoke to Chief Oncologist Dr. Morten Mau Sorensen and Dr. Kristian Egebjerg from Copenhagen University Hospital – Rigshospitalet in Denmark, whose research focuses on expanding HER2-targeted therapies to esophageal squamous cell carcinoma and improving diagnostic methods to identify HER2-positive patients across various cancer types.

Zitieren

APA

Sorensen, M. M., & Egebjerg, K. (2025). Unlocking the Potential of HER2-Targeted Treatments. EU Research, Spring 2025(41), 12-13. https://doi.org/10.56181//imii5025

Vancouver

Sorensen MM, Egebjerg K. Unlocking the Potential of HER2-Targeted Treatments. EU Research. 2025;Spring 2025(41):12-13. doi:10.56181//imii5025

BibTeX
@article{Sorensen2025,
  author = {Sorensen, Morten Mau and Egebjerg, Kristian},
  title = {Unlocking the Potential of HER2-Targeted Treatments},
  journal = {EU Research},
  year = {2025},
  volume = {Spring 2025},
  number = {41},
  pages = {12--13},
  doi = {10.56181//imii5025}
}
Kostenlos starten →